This was consistent with the decreased nuclear translocation of p65, a mandatory subunit for the activation of NF-κB pathway, in both BC-3 and BCBL-1 cells, while ATO or Lena alone did not display any effect on p65 translocation (Figure 3a). The gene discussed is NFKB1; the disease is breast cancer.